Sisram Medical Seeks to Raise Up To $176 Million in Hong Kong IPO
On September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange
Amarelle Wenkert | 16:45, 10.09.17
Last week, cosmetic surgery company Sisram Medical Ltd, a subsidiary of Singapore-based Fosun Pharma, submitted a prospectus to the Hong Kong Stock Exchange (HKEx).
More from CTech
Formerly known as Alma Lasers, the Israel-based company seeks to raise up to $176 million and is expected to begin trading on September 19.
After reviewing Israeli corporate legislation, the Hong Kong Stock Exchange sanctioned listing Israeli-registered companies. If successfully Sisram would become the first Israel-based company to be listed on the exchange.